Business
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
"The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing the third and last year of our current strategic plan," said Helen Giza, Chief Executive Officer of Fresenius Medical Care. "Revenue of both segments grew organically, and the phasing of the operating income development was in-line with our expectations. Care Enablement executed strongly against its transformation plan and further expanded its operating income ma
About this update from Fresenius Medical Care Ag
[{"type":"list","items":[{"val":[{"type":"text","content":"Strong organic revenue growth1 of 5% driven by Care Enablement and Care Delivery","length":80,"tagName":"p"}]},{"val":[{"type":"text","content":"Stable U.S. same market treatment development despite impact from a severe flu season","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"FME25 savings of EUR 68 million contributed to earnings","length":55,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating income2 grew 11% at constant currency resulting in margin expansion","length":77,"tagName":"p"}]},{"val":[{"type":"text","content":"Reported operating income grew by 35% and reported net income3 by 113%","length":70,"tagName":"p"}]},{"val":[{"type":"text","content":"Net leverage ratio further improved to 2.8x and FY 2025 outlook confirmed","length":73,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":440,"olType":false},{"type":"text","content":"BAD HOMBURG, Germany, May 6, 2025 /PRNewswire/ -- "The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing the third and last year of our current strategic plan," said Helen Giza, Chief Executive Officer of Fresenius Medical Care. "Revenue of both segments grew organically, and the phasing of the operating income development was in-line with our expectations. Care Enablement executed strongly against its transformation plan and further expanded its operating income margin, reaching its target margin band for the first time. Care Delivery maintained prior year´s margin level despite one dialysis day less and the negative impact from a severe flu season. Continuing last year´s positive momentum, patient referrals further increased. We therefore expect accelerating same market treatment growth in the U.S. to above 0.5% for the full year, after a stable development in Q1. We also continue to expect operational and financial improvements in both segments during the year, translating into significant earnings and margin growth. We therefore confirm our financial outlook for the full year 2025."","length":1203,"tagName":"p"},{"type":"image","alt":"Fresenius Medical Care starts the year with strong earnings growth (PRNewsfoto/Fresenius Medical Care North Am)","displaySize":"","headline":null,"caption":"Fresenius Medical Care starts the yea...